SLC39A10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.567600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.706400E-01
Normal-vs-Stage2
8.973400E-01
Normal-vs-Stage3
2.287400E-01
Normal-vs-Stage4
7.928000E-01
Stage1-vs-Stage2
6.563400E-01
Stage1-vs-Stage3
1.327840E-01
Stage1-vs-Stage4
9.051600E-01
Stage2-vs-Stage3
1.973410E-01
Stage2-vs-Stage4
8.281000E-01
Stage3-vs-Stage4
2.256400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.714200E-01
Normal-vs-AfricanAmerican
4.486400E-01
Normal-vs-Asian
6.685800E-01
Caucasian-vs-AfricanAmerican
2.725600E-01
Caucasian-vs-Asian
3.704600E-01
AfricanAmerican-vs-Asian
1.433010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.630200E-01
Normal-vs-Female
9.255000E-01
Male-vs-Female
8.820200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.418600E-01
Normal-vs-Age(41-60Yrs)
6.036400E-01
Normal-vs-Age(61-80Yrs)
9.247800E-01
Normal-vs-Age(81-100Yrs)
7.004200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.440400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.192000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.684000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.062500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.153430E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.198400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.318200E-01
Normal-vs-Daily Drinker
7.264400E-01
Normal-vs-Weekly Drinker
5.603400E-01
Normal-vs-Occasional Drinker
5.677600E-01
Normal-vs-Social Drinker
8.499800E-01
Non Drinker-vs-Daily Drinker
5.352400E-01
Non Drinker-vs-Weekly Drinker
4.281200E-01
Non Drinker-vs-Occasional Drinker
1.623800E-01
Non Drinker-vs-Social Drinker
5.561400E-01
Daily Drinker-vs-Weekly Drinker
8.650200E-01
Daily Drinker-vs-Occasional Drinker
7.401600E-02
Daily Drinker-vs-Social Drinker
3.461600E-01
Weekly Drinker-vs-Occasional Drinker
5.906000E-02
Weekly Drinker-vs-Social Drinker
2.991000E-01
Occasional Drinker-vs-Social Drinker
4.959800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.217800E-01
Normal-vs-Grade 2
3.967700E-02
Normal-vs-Grade 3
5.942200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.098200E-02
Grade 1-vs-Grade 3
9.122700E-03
Grade 1-vs-Grade 4
2.217800E-01
Grade 2-vs-Grade 3
1.756170E-01
Grade 2-vs-Grade 4
3.967700E-02
Grade 3-vs-Grade 4
5.942200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.357000E-01
Normal-vs-NonDiabetic
9.177800E-01
Diabetic-vs-NonDiabetic
3.053000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.104800E-01
Normal-vs-NoPancreatitis
9.812400E-01
Pancreatitis-vs-NoPancreatitis
6.331000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.561600E-01
Normal-vs-N1
8.827800E-01
N0-vs-N1
4.856400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.909800E-01
Normal-vs-TP53-NonMutant
6.049400E-01
TP53-Mutant-vs-TP53-NonMutant
3.06090000001813E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
